Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Intervalo de año de publicación
1.
Int J Oral Maxillofac Surg ; 44(4): 427-32, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25467736

RESUMEN

In Mexico, there have been few studies on primary oral and sinonasal melanoma, an aggressive neoplasm with a low survival rate and few therapeutic alternatives. Further, there is limited information about its clinical and histopathological characteristics. The aim of this retrospective study was to describe the clinicopathological profile of these tumours in patients attending a major oncology reference centre in Mexico City over a 12-year period. Demographic and clinical data were obtained from the clinical charts, and histopathological features were evaluated. χ(2), Fisher's exact, and Mann-Whitney U-tests were used for analysis; significance was set at P<0.05. Thirty-three cases were studied (73% sinonasal melanoma (SNM) and 27% oral melanoma (OM)); 58% were female and the median age was 66 (Q1-Q3 55.5-75) years. Compared with OM patients, SNM patients had a shorter time to diagnosis (16.7 vs. 11.7 months, P=0.022), were identified at earlier stages (33.3% vs. 58.3%, P=0.010), and all presented symptoms (66.7% vs. 100%, P=0.015). All samples showed vertical growth and 96.9% exhibited pleomorphism. A higher proportion of cases with pleomorphism developed metastases at follow-up than those without (60% vs. 12.5%, P=0.026). The present study provides valuable information that could form the basis of future studies in the search for advanced therapy modalities.


Asunto(s)
Melanoma/patología , Neoplasias de la Boca/patología , Neoplasias de los Senos Paranasales/patología , Anciano , Demografía , Femenino , Humanos , Inmunohistoquímica , Masculino , Melanoma/epidemiología , Melanoma/terapia , México/epidemiología , Persona de Mediana Edad , Neoplasias de la Boca/epidemiología , Neoplasias de la Boca/terapia , Metástasis de la Neoplasia , Estadificación de Neoplasias , Neoplasias de los Senos Paranasales/epidemiología , Neoplasias de los Senos Paranasales/terapia , Estudios Retrospectivos
2.
Aust Dent J ; 57(3): 300-7, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22924352

RESUMEN

BACKGROUND: Several studies have shown the participation of MMPs in oral squamous cell carcinoma, the most frequent malignant neoplasm of the oral cavity. The expression of some MMPs correlates with a more aggressive biological behaviour. The objective of this study was to determine which MMPs and TIMPs were expressed in both neoplastic and peritumoural stromal cells in different histopathology areas. METHODS: Patients who underwent primary tumour neck dissection for oral squamous cell carcinoma were included. Immunoexpression of MMP-1, -2, -3, -7, -9, -11, -13, and TIMP-1 and -2 in different areas of pathologic specimens (in situ carcinoma, primary tumour, invasive front, distant invasion carcinoma, and lymph node metastasis) was evaluated. Enzyme expression on mucosa adjacent to tumour served as control. RESULTS: Thirty cases were included. Only 6 MMPs and 1 TIMP were expressed in the studied areas. Statistically significant differences in the number of cases with positive MMPs or TIMP expression, in both neoplastic and peritumoural cells, between control and the rest of the areas were observed. MMP-2 expression was constant in the areas with a more aggressive biological behaviour. CONCLUSIONS: MMP-2 expression may represent a dynamic interaction between host and tumour that favours the establishment of neoplastic cells at distant sites.


Asunto(s)
Carcinoma de Células Escamosas/enzimología , Metaloproteinasas de la Matriz/metabolismo , Neoplasias de la Boca/enzimología , Células Madre Neoplásicas/enzimología , Inhibidores Tisulares de Metaloproteinasas/metabolismo , Anciano , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Inmunohistoquímica , Metástasis Linfática , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/patología , Pronóstico
3.
Pathobiology ; 77(3): 147-54, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20516730

RESUMEN

A tumor bank (TB) is an ordered collection of neoplastic samples, normal tissue, and/or fluids preserved under optimal conditions, as well as storing patients' clinical information. The objective of this article is to outline the planning and logistics necessary for the functioning of the Instituto Nacional de Cancerología (INCan) TB in Mexico City. For the planning and logistics of a TB, several technical, legal, medical, structural, and physical aspects were considered, which can be grouped under four headings: (1) design and structure, (2) equipping the area and informatics, (3) ethical-legal aspects, and (4) sample collection, preservation, and quality control. One crucial element of interinstitutional interest will be the transfer of these concepts to the different oncological centers, integrating in this manner a network that enables the exploration of the different pathologies from therapeutic, epidemiological, and molecular points of view.


Asunto(s)
Academias e Institutos/organización & administración , Neoplasias/patología , Manejo de Especímenes/normas , Bancos de Tejidos/organización & administración , Academias e Institutos/economía , Academias e Institutos/legislación & jurisprudencia , Academias e Institutos/normas , Confidencialidad , Arquitectura y Construcción de Instituciones de Salud , Humanos , Consentimiento Informado , Propiedad Intelectual , México , Objetivos Organizacionales , Desarrollo de Programa , Control de Calidad , Bancos de Tejidos/economía , Bancos de Tejidos/legislación & jurisprudencia , Bancos de Tejidos/normas
4.
Lung Cancer ; 58(2): 184-90, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17659812

RESUMEN

The highest mortality due to cancer worldwide for both genders corresponds to lung cancer (1,179,000 deaths). In Mexico, the crude mortality rate due to lung cancer was of 5.01 per 10(5) inhabitants in 1979. The most important risk factor is smoking. The present study was aimed at analyzing the mortality due to lung cancer in Mexico, assessing data from each of the states constituting the Mexican Republic during the 1998-2004 period. Data were obtained from the National Institute of Statistics, Geography and Informatics (INEGI, for its initials in Spanish) corresponding to deaths due to lung cancer (1998-2004). We estimated the mean annual mortality rate (MAMR) for each of the 32 states of Mexico. We used the "World Population Standard". The MAMR was standardized according to age (ARS) direct method, and the standard error was determined by Poisson's approximation at a 95% confidence interval. To know the excess risk due to mortality, we calculated the standardized mortality ratios (SMRs) of ARS for each federal state, using the national rate as reference. In this period, 397,400 deaths due to malignant neoplasms were recorded, corresponding 45,578 (11.5%) to lung cancer; for men, 31,025 (68.1%) with MAMR of 8.9 and the respective ARS of 13.2 both x10(5) inhabitants. For women, results were 4553 (31.9%) deaths with MAMR of 4.1 and ARS of 5.4 both x10(5) inhabitants. The highest mortality rates due to lung cancer in both genders were observed in the north of Mexico, whereas for women this was observed in the central states. Although smoking is the main risk for lung cancer, there are other factors such as environmental pollution or exposure to toxicants that could be associated to this cancer. The years potentially lost due to lung cancer were 258,550 for men and 133,315 for women, with a total of 391,865 according to histopathology registry neoplasm malignant RHNM (1985-1995). Studies focused on the characterization and measurement of polluting agents would be a good start to determine the level of participation of air pollution in the development of lung cancer.


Asunto(s)
Neoplasias Pulmonares/mortalidad , Anciano , Femenino , Geografía , Humanos , Masculino , México/epidemiología , Caracteres Sexuales
5.
Med Oral Patol Oral Cir Bucal ; 12(1): E30-3, 2007 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-17195824

RESUMEN

Polymorphous low-grade adenocarcinoma (PLGA) is difficult to diagnose both clinically and histologically due to its indolent presentation, and because of its morphological diversity that includes several microscopic patterns. The aggressive biologic behavior seen in minor salivary glands as compared to major glands is apparently associated histologically to a predominance of the papillary pattern in the former. Biologic behavior of PLGA in the major salivary glands is uncertain, as some cases have developed recurrences and metastases independently of the presence of a papillary pattern. A case of PLGA originated de novo in parotid gland is presented a 60 year-old male, treatment was surgically excised through superficial parotidectomy and to postoperative radiotherapy (46 Gy). Forty-eight months later the patient is alive with no signs of recurrence, as well as a review of the literature, with particular emphasis in its differential diagnosis and biological behavior.


Asunto(s)
Adenocarcinoma/patología , Neoplasias de la Parótida/patología , Adenocarcinoma/cirugía , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Parótida/cirugía
6.
Med. oral patol. oral cir. bucal (Internet) ; 12(1): E30-E33, ene. 2007. ilus, tab
Artículo en En | IBECS | ID: ibc-053418

RESUMEN

No disponible


Polymorphous low-grade adenocarcinoma (PLGA) is difficult to diagnose both clinically and histologically due to its indolent presentation, and because of its morphological diversity that includes several microscopic patterns. The aggressive biologic behavior seen in minor salivary glands as compared to major glands is apparently associated histologically to a predominance of the papillary pattern in the former. Biologic behavior of PLGA in the major salivary glands is uncertain, as some cases have developed recurrences and metastases independently of the presence of a papillary pattern. A case of PLGA originated de novo in parotid gland is presented a 60 year-old male, treatment was surgically excised through superficial parotidectomy and to postoperative radiotherapy (46 Gy). Forty-eight months later the patient is alive with no signs of recurrence, as well as a review of the literature, with particular emphasis in its differential diagnosis and biological behavior


Asunto(s)
Masculino , Persona de Mediana Edad , Humanos , Adenocarcinoma/patología , Neoplasias de la Parótida/patología , Adenocarcinoma/cirugía , Neoplasias de la Parótida/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...